Trial Profile
A clinical study to assess the feasibility of measuring inhaled medication concentrations in exhaled breath condensate obtained from healthy volunteers and asthma patients and to assess the relationship with clinical endpoints
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2020
Price :
$35
*
At a glance
- Drugs Salbutamol sulfate (Primary) ; Salbutamol sulfate (Primary) ; Tobramycin (Primary) ; Tobramycin (Primary)
- Indications Asthma
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 03 Nov 2020 Status changed from recruiting to completed.
- 21 Feb 2018 New trial record